Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release

Affiliations

• ¹ Department of Neuroscience, Imaging, Clinical Sciences, University G. d'Annunzio, Chieti-Pescara, Italy. giovanni.martinotti@gmail.com.
• ² Department of Pharmacy, Pharmacology, Clinical Sciences, University of Hertfordshire, Herts, UK. giovanni.martinotti@gmail.com.
• ³ Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
• ⁴ Section of Psychiatry, Department of Neuroscience, Ophthalmology, Genetics and Infant-Maternal Science, University of Genoa, Genoa, Italy.
• ⁵ Department of Psychiatry, Hospital Papa Giovanni XXIII, Bergamo, Italy.
• ⁶ Section of Psychiatry, Ospedali Riuniti, Polytechnic University of Marche, Ancona, Italy.
• ⁷ Department of Molecular Medicine, School of Medicine, University of Siena, Siena, Italy.
• ⁸ Department of Neuroscience, Imaging, Clinical Sciences, University G. d'Annunzio, Chieti-Pescara, Italy.